trending Market Intelligence /marketintelligence/en/news-insights/trending/erhv3jkbaje78q-o22gxaw2 content esgSubNav
In This List

Entellus Medical shareholders approve Stryker merger

Blog

Funding Social and Affordable Housing: A Credit Perspective

Blog

Global M&A By the Numbers: Q2 2021

Blog

Global Capital Markets & SPAC Activity – H1 2021

Blog

Gauging Supply Chain Risk In Volatile Times


Entellus Medical shareholders approve Stryker merger

Entellus Medical Inc. shareholders approved the Minnesota-based medical technology company's previously announced merger with Stryker Corp.

Shareholders voted to approve the deal at a special meeting held Feb. 26.

Under the transaction, which was recently cleared by the U.S. Federal Trade Commission, Michigan-based Stryker will pay Entellus shareholders $24 per share.

Entellus Medical makes products for the minimally invasive treatment of patients with chronic and recurrent sinusitis.